Dumbposter,
"There are an estimated 6,000 to 9,000 cases of Rett syndrome in the U.S. and a diagnosed population of 4,500 patients"
4500 registered as diagnosed in the USA of the estimated prevalence. Not an estimate. An actual register.
I am assuming that the number diagnosed will increase in the next 3-4 years now that there is a recognised treatment for it. Yes we can speculate what the diagnosed level will rise to from the current 4,500. I'd say to at least 6000-7500.
Take 80% of that if you like for withdrawal although there were a number of practical reasons people went off the trial, like travel distance which will not apply, but happy to be conservative at 80% retention.
Mateo's figures are consistent with the revenue generated already and the forecasts for the next quarter. That being 620 patients by then already.
Even at 80% retention you could comfortably predict 3000-4000 patients by 2026/2027
The revenue forecast for ROW was provided with the recent news.
I've been called a magician before but there ain't no hocus pocus here.
https://acadia.com/media/news-releases/acadia-pharmaceuticals-announces-u-s-fda-approval-of-daybue-trofinetide-for-the-treatment-of-rett-syndrome-in-adult-and-pediatric-patients-two-years-of-age-and-older/
- Forums
- ASX - By Stock
- Ann: Neuren and Acadia expand global partnership for trofinetide
Dumbposter,"There are an estimated 6,000 to 9,000 cases of Rett...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.80 |
Change
0.300(1.54%) |
Mkt cap ! $2.528B |
Open | High | Low | Value | Volume |
$19.49 | $19.92 | $19.25 | $5.352M | 271.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $19.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.80 | 516 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 19.780 |
2 | 1143 | 19.750 |
1 | 1441 | 19.740 |
1 | 5505 | 19.720 |
3 | 3263 | 19.700 |
Price($) | Vol. | No. |
---|---|---|
19.820 | 1081 | 2 |
19.890 | 150 | 1 |
19.900 | 2000 | 1 |
19.940 | 1143 | 2 |
19.950 | 1948 | 2 |
Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
Last
$19.80 |
  |
Change
0.300 ( 0.98 %) |
|||
Open | High | Low | Volume | ||
$19.41 | $19.92 | $19.25 | 77870 | ||
Last updated 15.59pm 17/06/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online